Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 4×

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566

The Many Pathways of RNA Degradation

Houseley, J. M., & Tollervey, D. W. (2009) · Cell · doi:10.1016/j.cell.2009.01.019 · Cited by 1,220

Lyophilization and development of solid protein pharmaceuticals

Wang, W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00423-3 · Cited by 1,178

Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines

Hassett, K. J., Benenato, K. E., Jacquinet, E., Lee, A., Woods, A., Yuzhakov, O., Himansu, S., Deterling, J., Geilich, B. M., Ketova, T., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.013 · Cited by 927

A thermostable mRNA vaccine against COVID-19

Zhang, N.-N., Li, X.-F., Deng, Y.-Q., Zhao, H., Huang, Y.-J., Yang, G., Huang, W.-J., Gao, P., Zhou, C., Zhang, R.-R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.024 · Cited by 671

Gene delivery by lipoplexes and polyplexes

de Ilarduya, C. T., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 626

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines

Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584

Vaccination and vaccine-preventable diseases in Africa

Sinumvayo, J. P., Munezero, P. C., Adegboyega, T. T., Adeyemo, R. O., Bale, M. I., Mutsaka‐Makuvaza, M. J., Daba, T. M., Nyandwi, J. B., Lambert, N., Mutumwinka, D., et al. (2024) · Scientific African · doi:10.1016/j.sciaf.2024.e02199 · Cited by 24

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis

Voss, C. J. D., Marcellus, Li, S., Ateere, A., McShane, H., & Stylianou, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1540359 · Cited by 20

Lipid nanoparticles driving mRNA vaccine innovations: From concept to clinic

Hariri, A., Mirian, M., Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2025) · Applied Materials Today · doi:10.1016/j.apmt.2025.102786 · Cited by 19

Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach

Khan, N. T., Zinnia, M. A., & Islam, A. B. M. M. K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2024253 · Cited by 19

SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology

Pack, S. M., & Peters, P. J. (2022) · Vaccines · doi:10.3390/vaccines10020236 · Cited by 19

A Review of Different Vaccines and Strategies to Combat COVID-19

Sabitha, S., Shobana, N., Prakash, P., Padmanaban, S., Sathiyasree, M., Saigeetha, S., Chakravarthi, S., Uthaman, S., Park, I., & Samrot, A. V. (2022) · Vaccines · doi:10.3390/vaccines10050737 · Cited by 29

Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?

Mahony, T. J., Briody, T. E., & Ommeh, S. C. (2024) · Vaccines · doi:10.3390/vaccines12020152 · Cited by 22

Recent development of oral vaccines (Review)

Liu, Y., Lam, D. M., Luan, M., Zheng, W., & Ai, H. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12511 · Cited by 18

Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution

Agampodi, S. B., Mogeni, O. D., Chandler, R. E., Pansuriya, M., Kim, J. H., & Excler, J. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2395546 · Cited by 20

Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery

Driskill, M. M., Coates, I. A., Hurst, P. J., Rajesh, N. U., Dulay, M. T., Waymouth, R. M., Akahata, W., Matsuda, K., Smith, J., Jacobson, G. B., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113944 · Cited by 18

Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines

Sung, J. C.-C., Lai, N. C.-Y., Wu, K.-C., Choi, M.-C., Ho-Yi, C., Lin, J., Kuok, C.-N., Leong, W.-L., Lam, W.-K., Hamied, Y. K., et al. (2022) · Vaccines · doi:10.3390/vaccines10071014 · Cited by 18

Liposome stability and integrity

Giannopoulos‐Dimitriou, A., Saiti, A., Petrou, A., Vizirianakis, I. S., & Fatouros, D. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00022-5 · Cited by 20

The RNA ligation method using modified splint DNAs significantly improves the efficiency of circular RNA synthesis

Kim, Y., Kim, D.-H., An, D., Lim, Y., Seo, Y., Kim, H. K., & Kang, H.-Y. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2265165 · Cited by 17

NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines

Sentí, M. E., Ceccaldi, A., Luciani, M., Saber, N., Schürmann, P. J. L., Geerlings, M. W., Hölig, P., de Beer, J., Hannus, M., Campbell, F., et al. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1458636 · Cited by 17

Better, Faster, Stronger: Accelerating mRNA ‐Based Immunotherapies With Nanocarriers

Carvalho, H., Fidalgo, T. A. S., Acúrcio, R. C., Matos, A. I., Satchi‐Fainaro, R., & Florindo, H. F. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2017 · Cited by 16

Trehalose-loaded LNPs enhance mRNA stability and bridge in vitro in vivo efficacy gap

Liu, X., Song, H., Tao, L.-L., Zhai, Z., Huang, J., & Cheng, Y. (2025) · npj Vaccines · doi:10.1038/s41541-025-01253-3 · Cited by 16

Biophysical characterization of siRNA-loaded lipid nanoparticles with different PEG content in an aqueous system

Kim, K. H., Bhujel, R., Maharjan, R., Lee, J. C., Jung, H. S., Kim, N. A., Kim, N. A., & Jeong, S. H. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.07.013 · Cited by 19

Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles

Huang, K., Li, N., Li, Y., Zhu, J., Fan, Q., Yang, J., Gao, Y., Liu, Y., Gao, S., Zhao, P., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c20770 · Cited by 32

Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies

Fatima, M., An, T., & Hong, K. (2025) · Biomolecules · doi:10.3390/biom15030359 · Cited by 20

Nanobiotechnology-Enabled mRNA Stabilization

Xian, H., Zhang, Y., Yu, C., & Wang, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020620 · Cited by 19

Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta VariantPreprint

Huang, K., Li, N., Li, Y., Zhu, J., Fan, Q., Yang, J., Gao, Y., Liu, Y., Hou, Q., Gao, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.12.491597 · Cited by 16

Resilient COVID-19 vaccine supply chain: An optimization and simulation approach for multi-objective management

Khalilpoor, S., Kamran, M. A., & Solimanpur, M. (2025) · Transportation Research Part E Logistics and Transportation Review · doi:10.1016/j.tre.2025.104168 · Cited by 15

Leveraging mRNA Platform Technology to Accelerate Development of Vaccines for Some Emerging and Neglected Tropical Diseases Through Local Vaccine Production

Sparrow, E. G., Hasso-Agopsowicz, M., Kaslow, D. C., Singh, K., Rao, R., Chibi, M., Makubalo, L., Reeder, J. C., Kang, G., Karron, R. A., et al. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.844039 · Cited by 16

Biomaterial-Mediated Protein Expression Induced by Peptide-mRNA Nanoparticles Embedded in Lyophilized Collagen Scaffolds

Egberink, R. O., Zegelaar, H. M., Boujnouni, N. E., Versteeg, E. M. M., Daamen, W. F., & Brock, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081619 · Cited by 15

Current clinical status of new COVID-19 vaccines and immunotherapy

Nagpal, D., Nagpal, S., Kaushik, D. K., & Kathuria, H. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22661-1 · Cited by 17

Mucosal delivery of nanovaccine strategy against COVID-19 and its variants

Lee, J., & Khang, D. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.022 · Cited by 15

Translation of in vitro-transcribed RNA therapeutics

von der Haar, T., Mulroney, T. E., Hedayioglu, F. D. L., Kurusamy, S., Rust, M., Lilley, K. S., Thaventhiran, J. E. D., Willis, A. E., & Smales, C. M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1128067 · Cited by 14

Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants

Gonzalez, V. J., Li, L., Buarpung, S., Prahl, M. K., Robinson, J. F., & Gaw, S. L. (2023) · iScience · doi:10.1016/j.isci.2023.107549 · Cited by 15

Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology

Hınçer, A., Ahan, R. E., Aras, E., & Şeker, U. Ö. Ş. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00253 · Cited by 15

Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA Vaccine

Chalkias, S., Pragalos, A., Akinsola, A., Berman, G., Ampajwala, M., Meyer, J. W., Schoch, L., Zhou, W., Paila, Y. D., Deng, W., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf022 · Cited by 15

Opportunities and challenges of mRNA technologies in development of dengue virus vaccine

Liu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1520968 · Cited by 15

DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations

Neeli, P. K., Chai, D., Roy, D., Prajapati, S., & Bonam, S. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178716 · Cited by 14

Self-amplifying RNA (saRNA) and circular RNA (circRNA) vaccines: Progress, evidence gaps, and translational pathways for durable and scalable immunization

Paul-Chima, U. O., Okon, M. B., Ogenyi Fabian, C., Nnenna, U. J., & Ugwu, C. N. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2661120 · Cited by 18

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery

Hayes, G., Barbieri, B. D., Yilmaz, G., Shattock, R. J., & Becer, C. R. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00683 · Cited by 14

Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis

Hasan, M., Khatun, A., & Kogure, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122678 · Cited by 14

Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells

Choi, K. C., Lee, D. H., Lee, J., Lee, J. S., Lee, Y. K., Choi, M. J., Jeong, H. Y., Kim, M. W., Lee, C.-G., & Park, Y. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031388 · Cited by 14

Impact of climate change on vaccine responses and inequity

Zhang, K., Dang, Y., Li, Y., Tao, C., Hur, J., & He, Y. O. (2024) · Nature Climate Change · doi:10.1038/s41558-024-02192-y · Cited by 17

Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus

Hicks, P. D., Manzoni, T. B., Westover, J. B., Petch, R. J., Roper, B., Gowen, B. B., & Bates, P. F. (2024) · Vaccines · doi:10.3390/vaccines12121403 · Cited by 14

Influence of diverse storage conditions of double‐stranded RNA in vitro on the RNA interference efficiency in vivo insect Tribolium castaneum

Bai, M., Liu, Z., Zhou, Y., Xu, Q., Liu, T., & Tian, H. (2022) · Pest Management Science · doi:10.1002/ps.7171 · Cited by 14

The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine

Xu, J., Liu, M., Niu, X., Hanson, J., Jung, K., Ru, P., Tu, H., Jones, D. M., Vlasova, A. N., Saif, L. J., et al. (2022) · Viruses · doi:10.3390/v15010095 · Cited by 16

Preparation of targeted lipid nanoparticles for precision nucleic acid delivery

Geisler, H. C., Battistini, E., Thatte, A. S., Padilla, M. S., & Mitchell, M. J. (2026) · Nature Protocols · doi:10.1038/s41596-025-01330-w · Cited by 18

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis

Touray, B. J. B., Hanafy, M., Phanse, Y., Hildebrand, R., & Talaat, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188754 · Cited by 14

To probe the binding of TMPyP4 to c-MYC G-quadruplex with in water and in imidazolium-based ionic liquids using spectroscopy coupled with molecular dynamics simulations

Paradis, N. J., Clark, A. K., Gogoj, H., Lakernick, P. M., Vaden, T. D., & Wu, C. F. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120097 · Cited by 14

mRNA vaccine platforms and novel delivery systems: From mechanistic principles to clinical translation

Yang, Y., Sun, Y., Kang, X., & Wang, Y. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2597629 · Cited by 17

Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges

Pozharov, V. P., & Minko, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010194 · Cited by 12

Cesium–lead–halide perovskite triggered visual platform: a disposable paper-based nano-temperature sensor for cold chain transport

Cui, G., Li, M., Qileng, A., Yang, H. M., Chen, M., Liu, W., & Liu, Y. (2023) · Journal of Materials Chemistry C · doi:10.1039/d3tc01901b · Cited by 12

mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases

Brandi, R., Paganelli, A., D’Amelio, R., Giuliani, P., Lista, F. R., Salemi, S., & Paganelli, R. (2024) · Vaccines · doi:10.3390/vaccines12121418 · Cited by 13

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature

Aves, K.-L., Janitzek, C. M., Fougeroux, C. E., Theander, T. G., & Sander, A. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061301 · Cited by 12

Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs

Mossadeq, S., Shah, R., Shah, V., & Bagul, M. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02455-x · Cited by 13

Blended Block Polycation Micelles Enhance Antisense Oligonucleotide Delivery

Hanson, M. G., Grimme, C. J., Kreofsky, N. W., Panda, S., & Reineke, T. M. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00186 · Cited by 12

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery

Żak, M. M., Kaur, K., Yoo, J., Kurian, A. A., Adjmi, M., Mainkar, G., Yoon, S., & Zangi, L. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092176 · Cited by 12

An overview of protein-based SARS-CoV-2 vaccines

Suryawanshi, Y. R. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.09.013 · Cited by 12

Exploring the Potential and Advancements of Circular RNA Therapeutics

Wang, L., Wang, L., Dong, C., Liu, J., Cui, G., Gao, S., & Liu, Z. (2025) · Exploration · doi:10.1002/exp.20240044 · Cited by 15

Practical Considerations for Next-Generation Adjuvant Development and Translation

Lykins, W. R., & Fox, C. B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071850 · Cited by 12

Current mRNA-based vaccine strategies for glioma treatment

Mao, M., Yang, W., & Zhang, X. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104459 · Cited by 12

Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C

Mata, E., Broset, E., Matute, C., Stoian, A. M., Adame, S., Alejo, T., López, A., Andrés, B., Heredero, J., de Miguel, D., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01201-1 · Cited by 11

Phospholipid-Drug Conjugates in Cancer Therapy: Emerging Paradigms and Future Directions

Dudhat, K. R., Pirojiya, H., Bhalala, K., Mori, D., & Prajapati, B. G. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03175-8 · Cited by 12

An assessment of the strategy and status of COVID-19 vaccination in India

Gupta, S. L., Goswami, S., Anand, A., Naman, N., Kumari, P., Sharma, P., & Jaiswal, R. (2023) · Immunologic research · doi:10.1007/s12026-023-09373-5 · Cited by 11

Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants

Wang, R., Huang, X., Cao, T.-S., Sun, C., Luo, D., Qiu, H., Wu, M. L., Huang, X., Yu, C., Li, J., et al. (2022) · Virology · doi:10.1016/j.virol.2022.09.003 · Cited by 11

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant

Hayashi, H., Sun, J., Yanagida, Y., Otera, T., Sasai, M., Chang, C. Y., Tai, J. A., Nishikawa, T., Yamashita, K., Sakaguchi, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24519-5 · Cited by 11

mRNA vaccines and clinical research in Africa - From hope to reality

Saied, A. A. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106833 · Cited by 11

Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

Katopodi, T., Petanidis, S., Grigoriadou, E., Anestakis, D., Charalampidis, C., Chatziprodromidou, I. P., Floros, G., Eskitzis, P., Zarogoulidis, P., Koulouris, C., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040455 · Cited by 11

The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy

Song, J., Zhang, Y., Zhou, C., Zhan, J., Cheng, X., Huang, H., Mao, S., & Zong, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112037 · Cited by 10

The use of orthogonal analytical approaches to profile lipid nanoparticle physicochemical attributes

Davidson, C. G., Abdulrahman, R., Punnabhum, P., Cairns, M., Rattray, N. J. W., Capomaccio, R. B., Treacher, K. E., Perrie, Y., & Rattray, Z. (2024) · Nano Futures · doi:10.1088/2399-1984/ad70e6 · Cited by 10

Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release

Schnetzinger, F., Clénet, D., Gilbert, P., Guzzi, A., Paludi, M., Weusten, J. J. A. M., & Hesselink, R. (2024) · Vaccines · doi:10.3390/vaccines12091000 · Cited by 12

Colorimetric polymer nanofilm-based time-temperature indicators for recording irreversible changes of temperatures in cold chain

Kashem, M. N. H., Miao, K., Afnan, F., Mushfique, S., Singh, V. S., Wang, W., Liu, Q., & Li, W. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102432 · Cited by 10

Lessons for medical countermeasure development from unforeseen outbreaks

Mura, M., Trignol, A., Dault, E. L., & Tournier, J. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2471035 · Cited by 10

mRNA folding algorithms for structure and codon optimization

Ward, M., Richardson, M. O. G., & Metkar, M. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf386 · Cited by 12

Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine

Sciaccaluga, C., D’Ascenzi, F., Cameli, M., Gallotta, M., Menci, D., Antonelli, G., Banchi, B., Mochi, V., Valente, S., & Focardi, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.827237 · Cited by 10

Multi-Objective Optimization of a Heat Sink for the Thermal Management of a Peltier-Cell-Based Biomedical Refrigerator

Gragnaniello, L., Iasiello, M., & Mauro, G. M. (2022) · Energies · doi:10.3390/en15197352 · Cited by 10

Natural deep eutectic solvents protect RNA from thermal-induced degradation

Mattioli, R., Maggiore, A., Risola, D. D., Federico, R., D’Erme, M., Francioso, A., & Mosca, L. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109714 · Cited by 10

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants

Su, P., Zhang, L., Zhou, F., & Zhang, L. (2022) · MedComm · doi:10.1002/mco2.153 · Cited by 9

Iron Oxide Nanoparticle-Mediated mRNA Delivery to Hard-to-Transfect Cancer Cells

Huang, J., Lin, G., Juenke, T., Chung, S., Lai, N., Zhang, T., Zhang, T., & Zhang, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071946 · Cited by 9

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response

Sobczak, J. M., Barkovska, I., Baļķe, I., Rothen, D. A., Mohsen, M. O., Skrastiņa, D., Ogrina, A., Martina, B. E. E., Jansons, J., Bogans, J., et al. (2024) · Vaccines · doi:10.3390/vaccines12060661 · Cited by 9

Fast-Tracking Vaccine Manufacturing: CEPI’s Rapid Response Framework for the 100 Days Mission

Kim, J. M., Sabet-Azad, R., Patel, D., Malin, G., Askary, S. H., & Särnefält, A. (2025) · Vaccines · doi:10.3390/vaccines13080849 · Cited by 9

mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications

Joshi, R., Sharma, S., Kapoor, D. U., Prajapati, B. G., Huanbutta, K., & Sriamornsak, P. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00774 · Cited by 10

Differences in Demographics of Vaccinees, Access to, and Satisfaction with SARS-CoV-2 Vaccination Procedures between German General Practices and Mass Vaccination Centers

Jentzsch, A., Geier, A.-K., Bleckwenn, M., & Schrimpf, A. M. (2022) · Vaccines · doi:10.3390/vaccines10111823 · Cited by 9

mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2

Noor, R. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01168-3 · Cited by 9

Structure and dynamics of supercooled water in the hydration layer of poly(ethylene glycol)

Li, Y., Han, Z., Ma, C., Hong, L., Ding, Y., Chen, Y., Zhao, J., Liu, D., Sun, G., Zuo, T., et al. (2022) · Structural Dynamics · doi:10.1063/4.0000158 · Cited by 9

Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses

Ghafoor, D., Zeb, A., Ali, S. S., Ali, M., Akbar, F., Din, Z. U., Rehman, S. U., Suleman, M., & Khan, W. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2214228 · Cited by 9

Lipid‐Based Nanoparticles

Shah, S. R., Madhu, H., Soniwala, M. M., Mori, D., Vyas, A. J., Chauhan, A., & Prajapati, B. G. (2024) · doi:10.1002/9781394175482.ch7 · Cited by 9

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern

Garg, R., Liu, Q., van Kessel, J., Asavajaru, A., Uhlemann, E.-M. E., Joessel, M., Hamonic, G., Khatooni, Z., Kroeker, A., Lew, J. M., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.05.028 · Cited by 9

The role of mRNA vaccines in infectious diseases: a new era of immunization

Batisani, K. (2025) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-025-00246-3 · Cited by 10

Virus-Inspired mRNA Delivery Vehicle Enabled by a Multilayered Nucleic Acid Nanocapsule

Pal, S., Singla, D., Canete, R. C., Darkwah, J. B., Cannata, J. N., Hunte, M. L., Penales, I. B., Szczepanek, S. M., Ducongè, F., Smilowitz, H. M., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c12871 · Cited by 10

Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global Health

de Abreu, A. D. J. L., Mpande, C. A. M., Song, Y., Nicholson, M. W., Nannei, C., & Friede, M. (2026) · Vaccines · doi:10.3390/vaccines14040324 · Cited by 9

Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan

Roque, J. A., Lukesh, N. R., Hendy, D. A., Dixon, T. A., Islam, J., Ontiveros-Padilla, L. A., Pena, E. S., Lifshits, L. M., Simpson, S. R., Batty, C. J., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124076 · Cited by 9

Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy

Acúrcio, R. C., Kleiner, R., Vaskovich‐Koubi, D., Carreira, B., Liubomirski, Y., Palma, C., Yeheskel, A., Yeini, E., Viana, A. S., Ferreira, V., et al. (2024) · Advanced Science · doi:10.1002/advs.202404159 · Cited by 8

Lessons learned from COVID-19 pandemic: Vaccine platform is a key player

Alhashemi, S. H., Ahmadi, F., & Dehshahri, A. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.12.002 · Cited by 11

A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy

Yang, Y., Guo, J., Qi, J., Deng, W., Hu, J., Hasan, M. W., Deng, F., Zhou, Y. L., Song, Z., Deng, W., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03445-4 · Cited by 10

Nanoparticle-Mediated Gene Therapy in Women’s Health: Progress, Delivery Challenges, and the Need for Sex, Age, and Ancestry Informed Design

Maestas-Olguin, A., Dawson, M. M., Quartey, E., Ikwuemesi, P., & Lanier, O. L. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00445 · Cited by 7

Expanding global access to mRNA vaccines

Eshaghi, B., Langer, R., & Jaklenec, A. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-026-00424-8 · Cited by 8

A comparative study of freeze-drying heat transfer in polymeric vials and glass vials

Sarmadi, M., Holmes, S., Agha, R., Davenport, B., Weikart, C., & Thompson, T. N. (2023) · Scientific Reports · doi:10.1038/s41598-023-40777-3 · Cited by 7

Testing the Antigenic Potential of Transmembrane Proteins To Develop a Thermostable Tuberculosis MOF-Liposomal Vaccine

Kumari, S., Martinez-Garcia, J., Ehrman, R. N., Tang, W., Miles, J., Basak, P., Howlett, T. S., Wijesundara, Y. H., Wang, Z., Izzo, A. A., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00771 · Cited by 7

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing

Grau, S., Martín‐García, E., Ferrández, O., Martín, R., Vaquero, S. T., Gimeno, R., Magri, G., & Maldonado, R. J. (2022) · Vaccines · doi:10.3390/vaccines10040594 · Cited by 7

mRNA Delivery and Storage by Co-Assembling Nanostructures with Designer Oligopeptides

Feng, R., Chang, A. C. Y., Ni, R., Li, C. Y., & Chau, Y. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00397 · Cited by 7

A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage

Côrtes, N., Lira, A. A. D. L., da Silva, J. W., Carvalho, E., Prates-Syed, W. A., Hamaguchi, B., Durães‐Carvalho, R., Balan, A., Câmara, N. O. S., Cabral-Marques, O., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01163-4 · Cited by 6

Lymph node-targeted delivery of cancer vaccine with natural plant derivatives potentiates antitumor efficacy through improved antigen presentation

Mu, J.-K., Wei, Z., Chen, Z., Wang, P., Wang, H., & Cao, P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167320 · Cited by 6

CRISPR-Cas technologies: Emerging tools from research to clinical application

Hyeon, H., Hwang, S., Luo, Y., Shin, E., Yeom, J., Kim, H., Ryu, M., & Lee, K. (2025) · The Journal of Microbiology · doi:10.71150/jm.2504012 · Cited by 7

Investigation on a Freeze-Drying Process for Long-Term Stability of mRNA-LNPs

Khan, M. F. H., Perumal, A. S., & Kamen, A. (2026) · Vaccines · doi:10.3390/vaccines14030242 · Cited by 6

The stability landscape of mRNA vaccines: challenges and mitigation strategies

Zhong, L., Tao, L., Zhai, Z., Liao, L., Shi, C., Yao, S., & Liu, X. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128515 · Cited by 6

Addressing the Cold Reality of mRNA Vaccine Stability

Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W., & Mastrobattista, E. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.006 · Cited by 517

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

Voigt, E. A., Gerhardt, A., Hanson, D., Jennewein, M. F., Battisti, P., Reed, S., Singh, J., Mohamath, R., Bakken, J., Beaver, S., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00549-y · Cited by 89

Next-generation mRNA vaccines: strategies to overcome stability challenges

Algaissi, A. A., & Moni, S. S. (2026) · npj Vaccines · doi:10.1038/s41541-026-01502-z · Cited by 1

Part A: The stability of Adenoviral and mRNA based COVID-19 vaccines and the potential of HSA/ Part B: Characterisation of IgG A33 hFab’ and human serum albumin using hydrodynamic methods

Hammad, K. A. (2021) · Nottingham ePrints (University of Nottingham)